Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label pharmacokinetic and safety study of Augmentin XR in pediatric acute bacterial sinusitis
2015-004874-13Phase 4
- Sponsor
- GSK
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of amoxicillin + clavulanate in Acute bacterial rhinosinusitis (ABRS), sponsored by GSK. Primary endpoint: Pharmacokinetic parameters (T>MIC).
02
Drugs
amoxicillin + clavulanate
03
Conditions
Acute bacterial rhinosinusitis (ABRS)
Beyond the preview
Go deeper on 2015-004874-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004874-13.